These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 23714730)

  • 21. [The usefulness of PET/CT in lung cancer].
    Pinilla I; Gómez León N
    Radiologia; 2009; 51(3):248-60. PubMed ID: 19406442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of the quantitative metabolic volumetric measurement on 18F-FDG PET/CT in Stage IV nonsurgical small-cell lung cancer.
    Liao S; Penney BC; Zhang H; Suzuki K; Pu Y
    Acad Radiol; 2012 Jan; 19(1):69-77. PubMed ID: 22142679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of CT and positron emission tomography/CT coregistered images in planning radical radiotherapy in patients with non-small-cell lung cancer.
    Macmanus M; D'Costa I; Everitt S; Andrews J; Ackerly T; Binns D; Lau E; Ball D; Weih L; Hicks RJ
    Australas Radiol; 2007 Aug; 51(4):386-93. PubMed ID: 17635480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of the number of removed lymph nodes at lobectomy in patients with positron emission tomography-computed tomography-negative N2 non-small cell lung cancer.
    Tsai YM; Huang TW; Hsu HH; Cheng CY; Lin YC; Cheng YL; Chang H; Lee SC
    Onkologie; 2013; 36(9):492-6. PubMed ID: 24051925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the utility of whole-body MRI with and without contrast-enhanced Quick 3D and double RF fat suppression techniques, conventional whole-body MRI, PET/CT and conventional examination for assessment of recurrence in NSCLC patients.
    Ohno Y; Nishio M; Koyama H; Yoshikawa T; Matsumoto S; Takenaka D; Seki S; Tsubakimoto M; Sugimura K
    Eur J Radiol; 2013 Nov; 82(11):2018-27. PubMed ID: 24012452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endoscopic ultrasound as a first test for diagnosis and staging of lung cancer: a prospective study.
    Singh P; Camazine B; Jadhav Y; Gupta R; Mukhopadhyay P; Khan A; Reddy R; Zheng Q; Smith DD; Khode R; Bhatt B; Bhat S; Yaqub Y; Shah RS; Sharma A; Sikka P; Erickson RA
    Am J Respir Crit Care Med; 2007 Feb; 175(4):345-54. PubMed ID: 17068326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lung-cancer staging with PET-CT.
    Hung JJ; Jeng WJ; Liu JS
    N Engl J Med; 2009 Oct; 361(16):1606-7; author reply 1608. PubMed ID: 19842246
    [No Abstract]   [Full Text] [Related]  

  • 28. Baseline SUVmax at PET-CT in stage IIIA non-small-cell lung cancer patients undergoing surgery after neoadjuvant therapy: prognostic implication focused on histopathologic subtypes.
    Lee HY; Lee KS; Park J; Han J; Kim BT; Kwon OJ; Ahn YC; Ahn MJ; Park K; Kim J; Shim YM
    Acad Radiol; 2012 Apr; 19(4):440-5. PubMed ID: 22265854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lung-cancer staging with PET-CT.
    Kloecker G; Civelek C; Janjua M
    N Engl J Med; 2009 Oct; 361(16):1607; author reply 1608. PubMed ID: 19842247
    [No Abstract]   [Full Text] [Related]  

  • 30. Non-small cell lung cancer with unsuspected distant metastasis to the kidney seen on PET/CT.
    Barry-Brooks M; Yoo DC; Chaump M; Noto RB
    Med Health R I; 2012 May; 95(5):144-6. PubMed ID: 22808631
    [No Abstract]   [Full Text] [Related]  

  • 31. Intra-tumour 18F-FDG uptake heterogeneity decreases the reliability on target volume definition with positron emission tomography/computed tomography imaging.
    Dong X; Wu P; Sun X; Li W; Wan H; Yu J; Xing L
    J Med Imaging Radiat Oncol; 2015 Jun; 59(3):338-45. PubMed ID: 25708154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Re: 'PET-CT in non-small cell lung cancer staging-promises and problems'.
    Barnes D; Entwistle J
    Clin Radiol; 2008 Jan; 63(1):108-10. PubMed ID: 18068798
    [No Abstract]   [Full Text] [Related]  

  • 33. Impact of FDG PET/CT on delineation of the gross tumor volume for radiation planning in non-small-cell lung cancer.
    Spratt DE; Diaz R; McElmurray J; Csiki I; Duggan D; Lu B; Delbeke D
    Clin Nucl Med; 2010 Apr; 35(4):237-43. PubMed ID: 20305410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lung-cancer staging with PET-CT.
    Bruzzi JF
    N Engl J Med; 2009 Oct; 361(16):1606; author reply 1608. PubMed ID: 19828539
    [No Abstract]   [Full Text] [Related]  

  • 35. A follow-up of integrated positron emission tomography/computed tomography after curative resection of non-small-cell lung cancer in asymptomatic patients.
    Cho S; Lee EB
    J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1447-51. PubMed ID: 20005529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positron emission tomography combined with diagnostic chest computed tomography enhances detection of regional recurrence after stereotactic body radiation therapy for early stage non-small cell lung cancer.
    Ebright MI; Russo GA; Gupta A; Subramaniam RM; Fernando HC; Kachnic LA
    J Thorac Cardiovasc Surg; 2013 Mar; 145(3):709-15. PubMed ID: 23317944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidental finding of an endobronchial tumor by 18F-FDG PET/CT.
    Navales I; Garcia JR; Alvarez-Moro FJ; Navarro A; Escobar I; Lomeña F
    Rev Esp Med Nucl Imagen Mol; 2013; 32(4):271-2. PubMed ID: 23046638
    [No Abstract]   [Full Text] [Related]  

  • 38. Detection of nodal metastatic disease in patients with non-small cell lung cancer: comparison of positron emission tomography (PET), contrast-enhanced computed tomography (CT), and combined PET-CT.
    Ventura E; Islam T; Gee MS; Mahmood U; Braschi M; Harisinghani MG
    Clin Imaging; 2010; 34(1):20-8. PubMed ID: 20122515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Standard uptake value predicts survival in non-small cell lung cancer.
    Okereke IC; Gangadharan SP; Kent MS; Nicotera SP; Shen C; DeCamp MM
    Ann Thorac Surg; 2009 Sep; 88(3):911-5; discussion 915-6. PubMed ID: 19699919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 18F-FDG PET-CT: predicting recurrence in patients following percutaneous cryoablation treatment for stage I primary non-small-cell lung cancer.
    LoGiurato B; Matthews R; Safaie E; Moore W; Bilfinger T; Relan N; Franceschi D
    Nucl Med Commun; 2015 Sep; 36(9):908-13. PubMed ID: 25973693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.